An introduction to the current regulatory framework for advanced therapies, including the legislation on ATMPs, Tissues and Cells and some ethics specifics to consider in a do's and don'ts to reach an effective shortening of pharmaceutical development time.

Speaker: Roland Gordon-Beresford, Chief Regulatory Affairs / Intellectual Property Office - Novadip